1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The transition of assessing health technologies to social interventions in Sweden
(
- Contribution to journal › Article
- 2012
-
Mark
Cost-utility analysis of adjuvant therapies for breast cancer in iran
(
- Contribution to journal › Article
- 2011
-
Mark
Cost-effectiveness of etanercept treatment in early active rheumatoid arthritis followed by dose adjustment.
(
- Contribution to journal › Article
- 2009
-
Mark
Modeling the cost-effectiveness of treatment of rheumatoid arthritis with rituximab using registry data from Southern Sweden
(
- Contribution to journal › Article
- 2007
-
Mark
Comparison of the cost-effectiveness of infliximab in the treatment of ankylosing spondylitis in the United Kingdom based on two different clinical trials
(
- Contribution to journal › Article
- 2004
-
Mark
Rehabilitation benefits highly motivated patients: a six-year prospective cost-effectiveness study
(
- Contribution to journal › Article
- 2003
-
Mark
Predicting survival in cost-effectiveness analyses based on clinical trials.
(
- Contribution to journal › Article
- 2002
-
Mark
Health promotion and disease prevention as a complement to community health indicators - Working group 1
(
- Contribution to journal › Article
-
Mark
Do changes in surgical procedures for breast cancer have consequences for hospital mean length of stay? A study of women operated on for breast cancer in Sweden, 1980-95.
(
- Contribution to journal › Article